GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MedCap AB (OSTO:MCAP) » Definitions » ROE % Adjusted to Book Value

MedCap AB (OSTO:MCAP) ROE % Adjusted to Book Value : 2.88% (As of Sep. 2024)


View and export this data going back to 2004. Start your Free Trial

What is MedCap AB ROE % Adjusted to Book Value?

MedCap AB's ROE % for the quarter that ended in Sep. 2024 was 18.08%. MedCap AB's PB Ratio for the quarter that ended in Sep. 2024 was 6.27. MedCap AB's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 was 2.88%.


MedCap AB ROE % Adjusted to Book Value Historical Data

The historical data trend for MedCap AB's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MedCap AB ROE % Adjusted to Book Value Chart

MedCap AB Annual Data
Trend Apr14 Apr15 Apr16 Apr17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.15 2.31 3.94 4.05 3.75

MedCap AB Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.91 5.09 4.09 3.15 2.88

Competitive Comparison of MedCap AB's ROE % Adjusted to Book Value

For the Medical Devices subindustry, MedCap AB's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MedCap AB's ROE % Adjusted to Book Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, MedCap AB's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where MedCap AB's ROE % Adjusted to Book Value falls into.



MedCap AB ROE % Adjusted to Book Value Calculation

MedCap AB's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=18.33% / 4.89
=3.75%

MedCap AB's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=18.08% / 6.27
=2.88%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MedCap AB ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of MedCap AB's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


MedCap AB Business Description

Traded in Other Exchanges
Address
Sundbybergsvagen 1, Solna, SWE, 171 73
MedCap AB acquires and develops profitable, market-leading niche companies in the Nordic life science industry. It is diversified into two business areas namely Medical technology and Specialist medicines. Medical Technology mainly develops and sells various medical technology products and services. Its Specialist medicines develop and sell medicines within the regulatory classes of registered, extemporaneous and licensed medicines.

MedCap AB Headlines

From GuruFocus

MCAP Inc. Reports First Quarter 2022 EPS of $0.15 Per Share

By PRNewswire PRNewswire 06-18-2022

MetaCap Inc. Announces New Board Members

By PRNewswire PRNewswire 02-03-2022

MCAP Inc. Hires Anthony Mariniello in Equities Division

By PRNewswire PRNewswire 01-06-2023

MCAP Inc. Announces Acquisition of QwickBonds

By PRNewswire PRNewswire 02-02-2023

MCAP Inc. Reports Third Quarter 2022 EPS of $0.08 Per Share

By PRNewswire PRNewswire 10-17-2022

MCAP Inc. Reports First Quarter 2022 EPS of $0.15 Per Share

By PRNewswire PRNewswire 05-29-2022